20/20 Biolabs, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2024 | $-2.6M | $-2.6M | — | $2.2M |
| FY2025 | $-1.9M | $-1.9M | — | $516.2K |
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2024 | $-2.6M | $-2.6M | — | $2.2M |
| FY2025 | $-1.9M | $-1.9M | — | $516.2K |